Mitochondrial dysfunction and mitophagy in Parkinson’s disease: From mechanism to therapy

Mitochondrial dysfunction and mitophagy in Parkinson’s disease: From mechanism to therapy

Mitochondrial dysfunction is implicated in PD through both environmental exposure and genetic factors. Increased understanding of mitochondrial dysfunction and mitophagy in PD has identified new mechanisms and therapeutic opportunities. Identification of the up- and downstream regulators of PINK1/pa...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Malpartida, AB, Williamson, M, Narendra, DP, Wade-Martins, R, Ryan, BJ
Formato:	Journal article
Idioma:	English
Publicado em:	Cell Press 2020

Registos relacionados

Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease.
Por: Ryan, B, et al.
Publicado em: (2015)

Mitochondrial dysfunction and mitophagy in ADHD: Cellular and molecular mechanisms
Por: Mohammed M. Almutairi, et al.
Publicado em: (2024-12-01)

Mitochondrial Dynamics and Mitophagy in the 6-Hydroxydopamine Preclinical Model of Parkinson's Disease
Por: Maria F. Galindo, et al.
Publicado em: (2012-01-01)

Mitochondrial Dysfunction in Parkinson's Disease
Por: P. C. Keane, et al.
Publicado em: (2011-01-01)

Modulating mitophagy in mitochondrial disease.
Por: Dombi, E, et al.
Publicado em: (2017)

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection
Por: Ross B. Mounsey, et al.
Publicado em: (2011-01-01)

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease
Por: Alexander Blagov, et al.
Publicado em: (2024-01-01)

Detecting mitophagy in mitochondrial disease: towards a new type of therapy
Por: Dombi, E
Publicado em: (2019)

Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
Por: Smith, A, et al.
Publicado em: (2018)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
Por: Booth, H, et al.
Publicado em: (2017)

Influence of aging, mitochondrial dysfunction, and inflammation on Parkinson’s disease
Por: Davide Cossu, et al.
Publicado em: (2024-01-01)

Mitochondrial dysfunction: mechanisms and advances in therapy
Por: Yao Zong, et al.
Publicado em: (2024-05-01)

Mitochondrial pathways of copper neurotoxicity: focus on mitochondrial dynamics and mitophagy
Por: Michael Aschner, et al.
Publicado em: (2024-12-01)

Diversity in the Regulation of Autophagy and Mitophagy: Lessons from Parkinson's Disease
Por: Charleen T. Chu
Publicado em: (2011-01-01)

Inflammation and mitophagy are mitochondrial checkpoints to aging
Por: Emma Guilbaud, et al.
Publicado em: (2024-04-01)

A novel mechanism of PHB2-mediated mitophagy participating in the development of Parkinson's disease
Por: Yongjiang Zhang, et al.
Publicado em: (2024-01-01)

αSynuclein and Mitochondrial Dysfunction: A Pathogenic Partnership in Parkinson’s Disease?
Por: David Protter, et al.
Publicado em: (2012-01-01)

The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors
Por: Yihong Liu, et al.
Publicado em: (2025-02-01)

Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First?
Por: Michela Zaltieri, et al.
Publicado em: (2015-01-01)

Potential Applications of Mitochondrial Therapy with a Focus on Parkinson’s Disease and Mitochondrial Transplantation
Por: Pranay Wal, et al.
Publicado em: (2024-03-01)

α-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.
Por: Ryan, B, et al.
Publicado em: (2014)

Cardiovascular disease: Mitochondrial dynamics and mitophagy crosstalk mechanisms with novel programmed cell death and macrophage polarisation
Por: Dandan Liu, et al.
Publicado em: (2024-08-01)

Roles of Mitochondrial Dysfunction in Diabetic Kidney Disease: New Perspectives from Mechanism to Therapy
Por: Yichen Yang, et al.
Publicado em: (2024-06-01)

Targeting alpha-synuclein as a therapy for Parkinson’s disease
Por: Fields, CR, et al.
Publicado em: (2019)

Mitophagy plays a central role in mitochondrial ageing
Por: Diot, A, et al.
Publicado em: (2016)

Mitochondrial dysfunction and Parkinson’s disease — near-infrared photobiomodulation as a potential therapeutic strategy
Por: Foo, Aaron Song Chuan, et al.
Publicado em: (2021)

The Nrf2/ARE Pathway: A Promising Target to Counteract Mitochondrial Dysfunction in Parkinson's Disease
Por: Kemal Ugur Tufekci, et al.
Publicado em: (2011-01-01)

Mitochondrial Stress Signalling: HTRA2 and Parkinson's Disease
Por: Enrico Desideri, et al.
Publicado em: (2012-01-01)

Aldehyde Dehydrogenase 2 Lactylation Aggravates Mitochondrial Dysfunction by Disrupting PHB2 Mediated Mitophagy in Acute Kidney Injury
Por: Jiaying Li, et al.
Publicado em: (2025-02-01)

The role of mitochondrial dynamics and mitophagy in skeletal muscle atrophy: from molecular mechanisms to therapeutic insights
Por: Yuhang Lei, et al.
Publicado em: (2024-04-01)

Dysfunctional Mitochondria Clearance in Situ: Mitophagy in Obesity and Diabetes-Associated Cardiometabolic Diseases
Por: Songling Tang, et al.
Publicado em: (2024-07-01)

Investigating the effects of autophagic perturbations on mitochondrial function in Parkinson’s Disease
Por: Ryan Barlow Patterson
Publicado em: (2019)

Mitochondrial dysfunction and energy changes of black-substance neurons in experimental parkinson's disease in rats and mothors
Por: N. M. Buchakchyiska, et al.
Publicado em: (2021-09-01)

Binding of α-synuclein to ACO2 promotes progressive mitochondrial dysfunction in Parkinson's disease models
Por: Jie Jiao, et al.
Publicado em: (2024-11-01)

The effect of training on mitochondrial mitophagy factors in obese male rats
Por: Mozhgan Ahmadi, et al.
Publicado em: (2022-04-01)

In vivo Mitophagy Monitoring in Caenorhabditis elegans to Determine Mitochondrial Homeostasis
Por: Konstantinos Palikaras, et al.
Publicado em: (2017-04-01)

Hippocampal mitophagy alterations in MAPT-associated frontotemporal dementia with parkinsonism
Por: Tyrique Richardson, et al.
Publicado em: (2025-02-01)

Mitochondria-targeted oligomeric α-synuclein induces TOM40 degradation and mitochondrial dysfunction in Parkinson’s disease and parkinsonism-dementia of Guam
Por: Velmarini Vasquez, et al.
Publicado em: (2024-12-01)

SLC5A3 depletion promotes apoptosis by inducing mitochondrial dysfunction and mitophagy in gemcitabine-resistant pancreatic cancer cells
Por: Minsoo Kim, et al.
Publicado em: (2025-03-01)

Targeting PHB2-mediated mitophagy alleviates nonesterified fatty acid-induced mitochondrial dysfunction in bovine mammary epithelial cells
Por: Guojin Li, et al.
Publicado em: (2024-10-01)